Official UK procurement notice
NHS National Framework for Trastuzumab 600mg Subcutaneous Injection
Authority: NHS England (Central government)
What is being bought
Published requirement descriptionProject title: NHS National Framework for Trastuzumab 600mg Subcutaneous Injection
Offer reference number: CM/TNS/26/5762
Period of framework: 1 June 2027 to 31 August 2028 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.
Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England
CPV: Pharmaceutical products
How this framework works
From the published notice- Framework period
- 1 yr 3 mo · up to 3 yrs 3 mo from 1 Jun 2027
The lotProcurement structure
single lot · no lot value publishedLot #1PlannedRenewal
What it takes to wini
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Evaluation split and conditions of participation as published; the tender pack may add morei
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
- “NHS National Framework for Trastuzumab 600mg Subcutaneous Injection” is a framework: the contest is a place on its panel, not a single contract.
Pipeline intelligence · planning stage: how this market runs before the tender is published
How NHS England buys Pharmaceutical products (CPV 3360), and who usually turns up
NHS England’s own published record, next to the published market for the same work. This notice is a framework or DPS, so only frameworks and DPS are compared. Whole-market view: Pharmaceutical products (CPV 3360) →
How the contest usually goes
Winner shares use published awards; bid and price charts use contested lots.
i
How often small and medium firms win.
Share of awards where the winner’s size is known.
The counts under this question show how many awards have a known supplier size.
Small firms have won here. Neither number says whether you qualify; it describes who has been winning.
i
How often local firms win similar work.
Winners with a registered address in the delivery region, out of awards with a known address.
A local branch does not count if the registered address is elsewhere.
No winner locations published for this authority. Local means a registered address in the delivery region.
i
How long buyers here take to decide after bids close.
Middle value in days from the deadline to the first award notice, on competitions that published both dates.
Only decided tenders count, so slow ones still waiting are not in.
Half of these awards were announced within 27 days of the bid deadline.
i
How often work is awarded with no recorded rival.
Direct awards and tenders where every published lot count shows one bid.
Thin markets produce this too; it is not proof of a tailored specification.
Awards are recorded, but published direct routes and bid counts do not establish this buyer’s share.
How many bids did past lots attract?
i
How many bids past lots received.
Each colour is a bid-count range. Only competed lots with a published count are included.
Past bids do not predict this tender.
1 bid14%
2–322%
4–615%
7+48%
How did awards compare with estimates?
i
Where winning prices landed against estimates.
Each colour shows awards below, close to or above the published estimate, one lot at a time.
On a framework or DPS, prices are agreed when work is called off.
Past prices are a guide, not a bid price.
Not comparable on a framework or DPS. The notice sets up a supplier panel and a ceiling value; what the work actually costs is agreed later, on each call-off or mini-competition, and those publish as contract notices of their own. The award-vs-estimate record of this market therefore sits on the call-offs; this page shows it on the contracts, not on the panel that frames them.
Assess each lot i
What past awards tell you about each lot.
See the forecast, this buyer’s earlier suppliers and firms with relevant wins.
No supplier is confirmed as a bidder.
i
What past awards tell you about each lot.
See the forecast, this buyer’s earlier suppliers and firms with relevant wins.
No supplier is confirmed as a bidder.
Open a lot for its forecast, this buyer’s previous supplier and possible competitors, from published award history, not a bid list
Our matching links this notice to “NHS National Framework for Denosumab Injection commencing 1st January 2026” and “NHS National Framework for the supply of Tocilizumab Injection” of this authority, but none of the 8 panel members sit in a category matching this notice.
Lot #1CPV 3360Published estimate£86m
i
How many bids this lot may attract.
The forecast uses similar past competitions. The bar shows either that forecast or past bid counts; the line below says which.
Each lot shows its own forecast based on its own category; forecasts for different lots of the same notice are not comparative. The bar shows 95 past lots.
A forecast, not a list of bidders.
1 bid20%
2–323%
4–628%
7+28%
i
Where the award price may land.
The forecast uses similar awards and the buyer’s estimate. The band covers the middle half of likely prices.
No comparable awards for this lot yet.
A statistical guide from past awards, not a price to bid.
Who has supplied this buyer on similar work? i
Who has done similar work for this buyer.
Past contracts are matched by buyer, title and type of work.
A past supplier may not bid again.
i
Who has done similar work for this buyer.
Past contracts are matched by buyer, title and type of work.
A past supplier may not bid again.
| Supplier | This buyer’s earlier contract | Lot | Award value | Why listed |
|---|---|---|---|---|
| NOVARTIS PHARMACEUTICALS UK LIMITEDEarlier contract | NHS National Framework Agreement for Omalizumabstarted Feb 2026 | Lot 1 - CM/TNS/25/5734 | — | Matched as the earlier contract |
| Biogen Idec LtdEarlier contract | National Framework Agreement for Adalimumab Injection 1 April 2023ended Feb 2025 | Lot 2 - CM/PHR/22/5660/02 - NHS Framework Agreement for the supply of Adalimumab | — | Matched as the earlier contract |
| Abbvie LtdEarlier contract | National Framework Agreement for Adalimumab Injection 1 April 2023ended Feb 2025 | Lot 2 - CM/PHR/22/5660/02 - NHS Framework Agreement for the supply of Adalimumab | — | Matched as the earlier contract |
| Orifarm UKEarlier contract | NHS National Framework for Golimumab Injectionstarted Nov 2025 | — | — | Matched as the earlier contract |
| Janssen-Cilag LtdEarlier contract | NHS National Framework for Golimumab Injectionstarted Nov 2025 | — | — | Matched as the earlier contract |
Who could compete for this lot? i
Who could compete for this lot?
Firms with relevant past wins. On a framework, we show firms on that agreement.
None is confirmed as a bidder.
i
Who could compete for this lot?
Firms with relevant past wins. On a framework, we show firms on that agreement.
None is confirmed as a bidder.
Candidate suppliers for this notice have not been worked out yet, so this is not a verdict that nobody fits.
About this data
- Source. Official UK public procurement notices (Find a Tender), reused under the Open Government Licence v3.0. New notices arrive through the day; the figures are rebuilt nightly.
- Two views, kept apart. The authority’s own track record and the wider market for the same kind of work sit side by side and are never mixed. Where the local picture is too thin, a figure widens to a broader market and says which one it used.
- Forecasts are labelled. The price forecast and its range, possible competitors and the earlier-work matches are our estimates from past awards: not published facts, not win chances and not price advice. Official notices do not say who is bidding.
- Every figure shows what it rests on. Not every notice publishes a bid count, a value or a delivery region, so each figure carries the number of records behind it, and one built on few records is marked as such. The on a figure explains it; the counting rules are in the methodology. Spotted something wrong? Tell us.
Procedure terms & legal framework
From the official record- Procedure method
- Open procedure
- Legal basis
- UKPGA · 2023/54 Procurement Act 2023
- Procurement category
- Goods
- Notice status
- Planned procurement
- Procurement threshold
- Above threshold (FTS publication)
- Regulatory regime
- Standard
- Commercial structure
- Framework agreement
- Who may use this agreement
- Not stated in the notice; call-off rights may be limited to the establishing authority
- Competition type
- Competitive procedure
- GPA / WTO covered
- Unspecified in notice
- Recurring procurement
- Unspecified in notice
- First published
- 3 Jul 2026, 09:10 BST
- Last source update
- 5 Aug 2026, 12:07 BST
- Authority reference
C453067- FTS notice number
2026/S 000-074125- Latest notice
- Preliminary market engagement notice (UK2)
- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-06c2f7Find a Tender
How it was run
Official notice- Appointment period ends
- —
Timeline
3 Jul 2026 → 1 Jun 2027 · 5 dates- Planning notice published112 days ago3 Jul 2026, 09:10 BST
- Latest notice published78 days ago5 Aug 2026, 12:07 BST
- Market engagement64 days ago19 Aug 2026, 23:59 BST
NHS England is seeking to engage with current or potential new suppliers that are planning to launch any of the molecule(s) that will be covered by this procurement. Interested suppliers will be invited to a virtual preliminary market engagement meeting.
The purpose of these sessions is to update suppliers regarding timelines and to discuss product details, product launches during the proposed framework period, tender structure, and KPI's.
Please contact [email protected] or [email protected] to register your interest in tendering for this framework.
- Tender notice expected51 days ago1 Sept 2026, 23:59 BST
- Today23 Oct 2026
- Contract startsin 221 days1 Jun 2027, 00:00 BST
Notice history
3 events · 2 releases on Find a Tender · since 3 Jul 2026- Pipeline notice published3 Jul 2026, 09:10 BSTUK1
- Preliminary market engagement notice published5 Aug 2026, 12:07 BSTUK2
- Published value updated to £85,800,0005 Aug 2026, 12:07 BSTwas £79,200,000
Commercial outcome & contract awards
Pipeline notice- Awards (0)
- No award published
- Contracts (0)
- No contract published
- Bid statistics
- No aggregate bid statistics published
Contracting authority & participating public bodies
Official documents & specifications (2)
Official links; attachments are not copiedNotices published for this procedure
- Preliminary market engagement notice Preliminary market engagement notice on Find a Tender
- Pipeline notice Pipeline notice on Find a Tender